SCHEMBL7803575

SCHEMBL7803575

COC(=O)Oc1ccc(OC(=O)OC)c2ccccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 3/20 0.58
KDM4E B2RXH2 3/20 0.58
HPGD P15428 1/20 0.58
TSHR P16473 2/20 0.51
PKM P14618 1/20 0.51
NPC1 O15118 1/20 0.51
RAB9A P51151 1/20 0.51
PLK1 P53350 1/20 0.49
LMNA P02545 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NCEH1 Q6PIU2 5/20 0.46
ALDH1A1 P00352 2/20 0.46
GAA P10253 2/20 0.46
PGR P06401 1/20 0.46
PTGS1 P23219 1/20 0.46
MAPK1 P28482 1/20 0.46
JAK2 O60674 1/20 0.45
MAPT P10636 1/20 0.45
HTT P42858 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30003241 1.00 HSD17B10 (0.58) HSD17B10KDM4EHPGDTSHRPKM
SCHEMBL18837420 0.88 HSD17B10 (0.47) HSD17B10KDM4EHPGDTSHRPKM
SCHEMBL19244670 0.85 PLK1 (0.56) HSD17B10HPGDTSHRPKMNPC1
SCHEMBL29525161 0.84 HSD17B10 (0.67) HSD17B10KDM4EHPGDRAB9AL3MBTL1
SCHEMBL1598809 0.84 HSD17B10 (0.67) HSD17B10KDM4EHPGDRAB9AL3MBTL1
SCHEMBL11925422 0.84 KDM4E (0.70) HSD17B10KDM4EHPGDTSHRNPC1
SCHEMBL28684572 0.82 HSD17B10 (0.55) HSD17B10KDM4EHPGDRAB9ALMNA
SCHEMBL23271942 0.82 TSHR (0.44) HSD17B10KDM4EHPGDTSHRPKM
SCHEMBL30003452 0.82 TSHR (0.44) HSD17B10KDM4EHPGDTSHRPKM
SCHEMBL3870181 0.81 HSD17B10 (0.42) HSD17B10KDM4EHPGDTSHRPKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
EP-0810205-B1 Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them HOECHST AG (DE) 2001-03-28 EP disclosed
EP-0810205-A1 Substituted 1-naphtoylguanidines, process for their preparation, their use as medicament or diagnostic agent and medicaments containing them HOECHST AKTIENGESELLSCHAFT (DE) 1997-12-03 EP disclosed
EP-0029972-A2 Preparation for brightening synthetic fibres, process for its preparation and process for optical brightening CASSELLA Aktiengesellschaft (DE) 1981-06-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC HSD17B10 2197/4885KDM4E 1028/4885HPGD 774/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC HSD17B10 2197/4885KDM4E 1028/4885HPGD 774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.